KDIGO guidelines include FILSPARI for IgA nephropathy treatment
Go back to KDIGO guidelines include FILSPARI for IgA nephropathy treatment| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 360.96 +18.86 (5.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $342.10 | 52 Week High | $114.49 | |||
| Open | $349.91 | 52 Week Low | $75.17 | |||
| Day High | $367.26 | P/E | 99.99 | |||
| Day Low | $356.10 | EPS | $3.61 | |||
| Volume | 813,221 | |||||
| (AMEX: CSLLY) | Delayed: 19.00 +0.59 (3.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.41 | 52 Week High | $45.60 | |||
| Open | $18.72 | 52 Week Low | $33.39 | |||
| Day High | $19.20 | P/E | N/A | |||
| Day Low | $18.50 | EPS | $0.00 | |||
| Volume | 371,663 | |||||
| (NASDAQ: TVTX) | Delayed: 55.15 +1.01 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.14 | 52 Week High | $ | |||
| Open | $54.65 | 52 Week Low | $ | |||
| Day High | $55.99 | P/E | N/A | |||
| Day Low | $53.75 | EPS | $ | |||
| Volume | 6,587,102 | |||||

